What is the safety profile of guselkumab in PsO and PsA?

Join Cassie Dolecki, a clinical pharmacy specialist in Rheumatology at Allegheny Health Network in Pittsburgh, Pennsylvania, as she discusses the safety profile of guselkumab in treating psoriatic arthritis and psoriasis. Cassie highlights findings from the DISCOVER-2 trial, a phase three study that assessed the efficacy and safety of guselkumab compared to placebo in biologic-naive patients with active psoriatic disease over two years.